Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.
- DOI
- 10.1007/s00535-026-02507-0
- Published
- 2026 Aug 28
- Container
- Journal of gastroenterology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00535-026-02507-0,
title = {Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.},
author = {Nakajima A and Okanoue T and Hiasa Y and Takahashi H and Opuni K and Kosaka N and Nishida T and Sanyal AJ},
year = {2026},
journal = {Journal of gastroenterology},
doi = {10.1007/s00535-026-02507-0},
url = {https://doi.org/10.1007/s00535-026-02507-0}
}RIS
TY - JOUR TI - Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial. AU - Nakajima A AU - Okanoue T AU - Hiasa Y AU - Takahashi H AU - Opuni K AU - Kosaka N AU - Nishida T AU - Sanyal AJ PY - 2026 JO - Journal of gastroenterology DO - 10.1007/s00535-026-02507-0 UR - https://doi.org/10.1007/s00535-026-02507-0 ER -
APA
A, N., T, O., Y, H., H, T., K, O., N, K., T, N., & AJ, S. (2026). Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.. Journal of gastroenterology. https://doi.org/10.1007/s00535-026-02507-0
Source records
- pubmed · retrieved 2026-09-25T19:06:23.437Z